---
figid: PMC9221178__cancers-14-02923-g005
figtitle: Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression
organisms:
- Streptococcus pyogenes
- Fusobacterium nucleatum
- Serratia marcescens
- Mycobacterium intracellulare subsp. intracellulare
- Clostridium novyi NT
- Clostridium novyi
- Adenoviridae
- unidentified influenza virus
- Vaccinia virus
- DNA viruses
- Papaya mosaic virus
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Toxoplasma gondii
- Homo sapiens
- Canis lupus familiaris
- Vigna unguiculata
pmcid: PMC9221178
filename: cancers-14-02923-g005.jpg
figlink: /pmc/articles/PMC9221178/figure/cancers-14-02923-f005/
number: F5
caption: TLR–IFN signaling in anti-tumor responses. TLRs use a MyD88-independent pathway
  for IFN signaling. Upon TLR stimulation, membrane-localized TLRs (i.e., TLR4) activate
  TRIF through adaptor protein TRAM. TRIF activates TRAF3, which activates the TBK1–IKKε
  complex. The TBK–IKKε complex phosphorylates IRF3. Endosome-localized TLR3 activates
  TRIF directly. Following TRIF activation, TRAF3 is activated and shares downstream
  IFN signaling steps with membrane-localized TLRs. TLR–IFN signaling induces type
  I IFN production, apoptosis, and activation of immune cells. Created with Biorender.com.
papertitle: Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression.
reftext: Eileena F. Giurini, et al. Cancers (Basel). 2022 Jun;14(12):2923.
year: '2022'
doi: 10.3390/cancers14122923
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: innate receptors | toll like receptors | cancer | immunotherapy | microbial
  based therapy
automl_pathway: 0.9233155
figid_alias: PMC9221178__F5
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Rattus norvegicus
redirect_from: /figures/PMC9221178__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9221178__cancers-14-02923-g005.html
  '@type': Dataset
  description: TLR–IFN signaling in anti-tumor responses. TLRs use a MyD88-independent
    pathway for IFN signaling. Upon TLR stimulation, membrane-localized TLRs (i.e.,
    TLR4) activate TRIF through adaptor protein TRAM. TRIF activates TRAF3, which
    activates the TBK1–IKKε complex. The TBK–IKKε complex phosphorylates IRF3. Endosome-localized
    TLR3 activates TRIF directly. Following TRIF activation, TRAF3 is activated and
    shares downstream IFN signaling steps with membrane-localized TLRs. TLR–IFN signaling
    induces type I IFN production, apoptosis, and activation of immune cells. Created
    with Biorender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR4
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - TRIM69
  - TICAM1
  - TRAF3
  - IKBKE
  - TBK1
  - IRF3
  - IFNK
  - IFNW1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - TLR3
  - Tlr4
  - Tmed7
  - Ticam2
  - Rnf138
  - Trim69
  - Ticam1
  - Traf3
  - Ikbke
  - Tbk1
  - Irf3
  - Tlr3
---
